Jeff Schaffnit: Global Voices in Hemophilia Care at the World Federation of Hemophilia World Congress
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
“This week I had the privilege of joining the global hemophilia community at the World Federation of Hemophilia World Congress in Kuala Lampur, Malaysia.
The meeting was nothing short of inspiring—being in the room with clinicians, researchers, patient advocates and people living with hemophilia from around the world was a powerful reminder of why our work matters.
At Sanofi, we remain committed to advancing care for people with rare blood disorders, and moments like these continue to reinforce our team’s sense of urgency and purpose.
I’m grateful for the connections and conversations and look forward to what’s ahead.”
Stay updated with Hemostasis Today.
-
Apr 27, 2026, 06:44Andrew M. Evens: Award-Winning Research from the British Society for Haematology 66th Annual Meeting
-
Apr 27, 2026, 05:19Harshal Kale: Celebrating Hemophilia Partnerships on a Global Stage
-
Apr 26, 2026, 17:17Ajigbotosho Barakat: Leg Strength as a Key to Healthy Aging
-
Apr 26, 2026, 17:02Francisco Chacón-Lozsán: Limited Evidence Methylene Blue in Vasoplegic Shock
-
Apr 26, 2026, 16:57Gopal Patidar: Key Areas of Haemovigilance in ISBT Transfusion Today
-
Apr 26, 2026, 16:56Cathy Harrison: Oral Health in Older Adults Assessing the Impact of Ageing, Heart Failure, and Social Isolation
-
Apr 26, 2026, 15:08Andreas Ejlegård: Rebalancing Thrombosis and Hemostasis Through Mechanistic Innovation
-
Apr 26, 2026, 14:55Vanessa Simioni Faria: Precision Anticoagulation and Expanding Donor Frontiers
-
Apr 26, 2026, 14:52Flora Peyvandi: Results from the PROMISE Study Predicting Recurrent Stroke in Intracranial Atherosclerotic Stenosis